Tag: cardiovascular

Cognitive Deficits Linked to CV Risk Factors in Diabetes

In type 2 diabetes (T2D), a greater degree of hyperlipidemia and hypertension, although not hyperglycemia, was associated with measurable cognitive impairment even among patients with...

Women’s Heart Health Tied to Multiple Pregnancy Complications

Women with prepregnancy cardiovascular disease (CVD) risk factors have increasingly worse pregnancy outcomes, including a higher rate of maternal intensive care unit (ICU) admissions and...

Statins Again Linked to Lower COVID-19 Mortality

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Among patients hospitalized for COVID-19, those who had been taking statins...

Spouses Can Share Cardiac Event Risk

A study from Japan suggests that a history of cardiovascular (CV) events in a spouse may elevate risk for future CV events in the other...

CTA May Guide Primary Prevention Statins in Nonobstructive CAD

The relative risk of death or myocardial infarction (MI) went down with statin therapy in a cohort study of patients with either nonobstructive coronary artery...

South Asian Ancestry Linked to Increased Risk for Heart Disease

Individuals of South Asian ancestry face twice the risk of heart disease, compared with individuals of European descent, yet existing risk calculators fail to account...

No Sequelae From Lab Abnormalities in Isotretinoin Study

Isotretinoin use contributed to abnormal lipid lab values in pediatric patients, but no secondary effects were observed, results from a single-center retrospective study demonstrated. “Isotretinoin...

Positive Top-Line Results for Empagliflozin in HFpEF

Treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly) significantly reduces the risk of cardiovascular death or hospitalization for heart failure...

Midlife Change in Wealth May Be Costly for Heart Health

Midlife changes in wealth may affect a patient’s risk of cardiovascular disease, a new cohort study suggests. It found that upward wealth mobility relative to...

Assays May Guide SGLT2 Inhibitor Use in High CV-Risk Diabetes

Heart failure (HF) guidelines and practice have been quick to embrace the sodium-glucose cotransporter 2 (SGLT2) inhibitor drug class after DAPA-HF, EMPEROR-Reduced, and other trials...

Calories May Outweigh Nutrients in Diets for Fatty Liver

Intermittent calorie restriction offers only modest advantages over a low-carbohydrate, high-fat diet (LCHF) for treating nonalcoholic fatty liver disease (NAFLD), researchers say. The intermittent diet...

Unhealthy Diet Linked to CHIP Mutation and CVD

An unhealthy diet is associated with a higher prevalence of clonal hematopoiesis of indeterminate potential (CHIP), a genetic variation that researchers say is a novel...

Bariatric Surgery’s Cardiovascular Benefit Extends to 7 Years

Patients with obesity who had bariatric surgery had a lower risk of having a major adverse cardiovascular event (MACE) or dying from all causes during...

Real-world PCSK9i Data in FH Reveal Conundrum of Reimbursement

Patients with familial hypercholesterolemia (FH), particularly those with heterozygous FH, see their low-density-lipoprotein (LDL) cholesterol levels slashed with evolocumab (Repatha) and maintained out to 2...

Don’t Delay COVID Shot While CDC Reviews Myocarditis Cases

While the investigation into cases of myocarditis possibly associated with COVID vaccines proceeds, the American Heart Association (AHA)/American Stroke Association (ASA) continue to urge everyone...

Blood Sugar Control in Diabetes Is Getting Worse

Fewer adults with diabetes in the United States have well-controlled blood sugar or blood pressure now compared to 10 years ago, a trend that should...

Evidence Builds for iPhone 12 Interference With Cardiac Devices

Further evidence that powerful magnets in some Apple iPhones can interfere with cardiac implantable electronic devices (CIEDs) comes from a small study that also suggests...

Lipoprotein Apheresis Shows Durable Impact on CV Outcomes

Lipoprotein apheresis (LA) is a safe and effective treatment for very-high-risk dyslipidemia, sustainably reducing cholesterol and lipoprotein levels to within target levels and markedly lowering...

Dual Antiplatelet Therapy in Mild Stroke: Better at Lower BP?

Patients with mild stroke or high-risk transient ischemic attack (TIA) had a greater benefit from dual antiplatelet therapy if their blood pressure was lower at...

Adding Daily Steps Linked to Longer Life

Taking more steps each day, in short spurts or longer bouts, was associated with a longer life in women older than 60 years, according to...

Do Anti-ApoA-1 Antibodies Link Fatty Liver Disease and CVD?

Anti-apolipoprotein A-1 (ApoA-1) antibodies are common in non-alcoholic fatty liver disease (NAFLD) and may not only drive its development but also underlie the link between...

High ‘Remnant’ Cholesterol Linked to Fivefold Increase in PAD

Elevated levels of remnant cholesterol, or cholesterol other than high-density lipoprotein and low-density lipoprotein (LDL), are associated with a substantially increased risk of developing peripheral...

Transradial Complex PCI Effective With Slim, Large-Bore Sheath

Transradial vascular access is often preferred over the transfemoral route in percutaneous coronary intervention (PCI) for its lower associated risks of bleeding and vascular complications....

Both Higher Alcohol Intake and Genetic Predisposition Tied to CVD

Cardiovascular disease risk is associated with alcohol intake in general, but variations in risk exist with levels of intake, based on data from a genetic-based...

Being Firstborn Linked to Lower Heart Disease Risk

May 26, 2021 — Birth order and number of siblings may be tied to a person’s risk for heart disease and mortality, according to a study covering...